Department of Medicine III, Technische Universität Dresden, Dresden, Germany.
Department of Urology, Xiangya Hospital, Central South University, Changsha, China.
World J Urol. 2022 Feb;40(2):385-390. doi: 10.1007/s00345-021-03851-x. Epub 2021 Oct 16.
Paraganglioma of the urinary bladder (UBPGL) is a rare neuroendocrine tumor diagnosed in many patients only after surgery. We, therefore, assessed clinical clues relevant to presurgical diagnosis and clinical consequences in patients with a missed presurgical diagnosis of UBPGL.
Case reports describing a UBPGL (published from 1-1-2001 and 31-12-2020) were identified in Pubmed. Two authors independently performed data extraction and assessed data quality according to the PRISMA guideline. Patients were divided into two groups: UBPGL diagnosis before and after surgery.
We included 177 articles reporting 194 cases. In 90 (46.4%) patients, the UBPGL was diagnosed before and in 104 (53.6%) after surgery. In presurgically diagnosed UBPGL, hypertension and catecholamine-associated symptoms were 2- to 3-fold (p < 0.001) more frequent than in postsurgically diagnosed patients whereas hematuria was twofold (p = 0.003) more prevalent in those with postsurgical diagnosis. Hypertension was an independent factor for presurgical biochemical testing (OR 4.45, 95% CI 1.66-11.94) while hematuria (OR 0.23, 95% CI 0.09-0.60) was an independent factor for not performing presurgical biochemical testing. Most patients diagnosed after surgery were not pretreated with alpha-adrenoceptor blockade (95.2%), underwent more frequently transurethral resection instead of cystectomy (70.2% vs. 23.1%) and had more frequent peroperative complications and residual tumor mass.
In nearly half of all patients with a UBPGL, the diagnosis was not established before surgery. Hypertension and hematuria contributed independently to a presurgical diagnosis. Postsurgical diagnosis, which was associated with suboptimal presurgical and surgical management, resulted in more peroperative complications and incomplete tumor resections.
膀胱副神经节瘤(UBPGL)是一种罕见的神经内分泌肿瘤,许多患者只有在手术后才能确诊。因此,我们评估了与术前诊断相关的临床线索以及漏诊患者的临床后果。
在 Pubmed 上检索了描述 UBPGL 的病例报告(发表时间为 2001 年 1 月 1 日至 2020 年 12 月 31 日)。两名作者独立进行数据提取,并根据 PRISMA 指南评估数据质量。患者分为两组:手术前和手术后诊断为 UBPGL。
我们共纳入 177 篇文章,报道了 194 例病例。90 例(46.4%)患者在手术前诊断为 UBPGL,104 例(53.6%)在手术后诊断。在术前诊断的 UBPGL 患者中,高血压和儿茶酚胺相关症状的发生率是手术后诊断患者的 2-3 倍(p<0.001),而血尿的发生率则是手术后诊断患者的两倍(p=0.003)。高血压是术前生化检查的独立因素(OR 4.45,95%CI 1.66-11.94),而血尿(OR 0.23,95%CI 0.09-0.60)是不进行术前生化检查的独立因素。术后诊断的大多数患者未接受α-肾上腺素受体阻滞剂预处理(95.2%),更频繁地接受经尿道切除术而不是膀胱切除术(70.2%比 23.1%),且术中并发症和残余肿瘤组织更为常见。
近一半的 UBPGL 患者在手术前未确诊。高血压和血尿独立促进了术前诊断。术后诊断与术前和手术管理不理想有关,导致更多的术中并发症和肿瘤不完全切除。